CardioMech is a series a startup based in United States.
Based in Norway, Cardiomech is a startup founded in 2018. Brouky records 2 investors associated with the company.
Cardiomech develops a catheter-based artificial chord device for minimally invasive mitral valve repair to treat mitral regurgitation, offering an alternative to open-heart surgery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.